People | RAPID

Our People

RAPID is a collaborative team across pharmacokinetics, pharmacometrics, pharmacogenetics, and assay-linked translational research.

Core Researchers

Dr Shamin Mohd Saffian

Pharmacometrics • Clinical pharmacology • Thrombosis • Oncology • Antibiotics • Coagulation assays

Dr Nor Asyikin Mohd Tahir

Pharmacometrics • Pharmacogenetics • Antibiotics • Translational assay research

Affiliated Researchers

These researchers contribute to RAPID projects through collaborative work in pharmacokinetics, pharmacometrics, pharmacogenetics, and translational research.

Assoc Prof Dr Noraida Mohamed Shah

Immunoglobulin G PK • Clinical pharmacy practice • Adherence

Assoc Prof Dr Adyani Md Redzuan

Digoxin PopPK • Cardiovascular pharmacotherapy • Adherence

Prof Dr Mohd Makmor Bakry

ICU • Antibiotics PK • Pharmacogenetics • Critical care pharmacotherapy

Assoc Prof Dr Farida Hanim binti Islahudin

Clinical pharmacy practice • Pharmacogenetics • Nephrology • Infectious disease

Current Research Students

Toh Chin Chiang — Amikacin population PK in PICU
Tuan Fauziah Tuan Roslli — HDMTX population PK in lymphoma
Farah Aida A. Zairol Azwan — Allopurinol and oxypurinol PK/PD
Nazatul Adhwa Mohd Rozi — Piperacillin population PK in CRRT

Past Students

Master — Christian Andrew Almalbis (2025) — Apixaban and Rivaroxaban Therapy: Evaluation of risk scores, development of bleeding risk assessment tool and drug concentration review
Master — Ng Jia Wei (2024) — Safety, efficacy and variability of Dabigatran therapy
PhD — Lee Jian Lynn (2022) — Evaluation of immunoglobulin therapy and population pharmacokinetic model development

Supervised Work

Student projects supervised related to pharmacokinetics and dose individualisation.

Muhammad Nordin M. Saud (2025) — Extended-Infusion Meropenem in the Critically ill: When to Start First Maintenance Dosing?
Fann Zi Yin (2025) — Treatment outcomes in methicillin-resistant Staphylococcus aureus bacteraemia patients receiving vancomycin: a retrospective study at a tertiary hospital — DOI
Farah Waheeda Tajurudin (2024) — Analysis of direct oral anticoagulant (DOAC) prescriptions in atrial fibrillation patients two years post-discharge from DOAC clinic
Ahmad Salihin Abdullah (2021) — Bleeding and thromboembolic events in patients with non-valvular atrial fibrillation treated with apixaban or rivaroxaban in a single tertiary teaching hospital — DOI